{"abstract": "Talks between the French pharmaceutical giant Sanofi-Aventis and the American biotech company Genzyme have hit a snag as the two sides seek to agree on a threshhold price that would allow Sanofi to proceed with due diligence, The Wall Street Journal reports.", "web_url": "https://dealbook.nytimes.com/2010/08/24/sanofi-and-genzyme-talks-said-to-stall-on-price/", "snippet": "Talks between the French pharmaceutical giant Sanofi-Aventis and the American biotech company Genzyme have hit a snag as the two sides seek to agree on a threshhold price that would allow Sanofi to proceed with due diligence, The Wall Street Journ...", "lead_paragraph": "Talks between the French pharmaceutical giant Sanofi-Aventis and the American biotech company Genzyme have hit a snag as the two sides try to agree on a threshhold price that would allow Sanofi to proceed with due diligence, The Wall Street Journal reports.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi-Genzyme Talks Said to Stall on Price", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Icahn, Carl C", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis SA", "rank": 3, "major": "N"}], "pub_date": "2010-08-24T12:11:05+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/a09a9412-9c1f-5a9b-aea0-069479051990", "word_count": 160, "uri": "nyt://article/a09a9412-9c1f-5a9b-aea0-069479051990"}